Loading stock data…
EUDA
$15.28+0.75 (+5.16%)
Market ClosedLast close May 1
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
EUDA Health Holdings Limited in the Real Estate sector is trading at $15.28. The stock is currently near its 52-week low of $5.26, remaining 58.4% below its 200-day moving average. Technical signals show overbought RSI of 77 and bullish MACD crossover, explaining why EUDA maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 77) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$15.28
Potential Upside
815.9%
Whystock Fair Value$139.95
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus1 analysts
Mean target$55.00+259.9%
Range$55.00 – $55.00
Fundamentals
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The co...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.42M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
15.10
Beta
Defensive asset. Lower volatility than the S&P 500.
0.16
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
601.52%
Volume
Today's trading volume
120,983
Recent News
EUDA Health price target lowered to $2.75 from $6 at Greenridge
Greenridge analyst William Gregozeski lowered the firm’s price target on EUDA Health (EUDA) to $2.75 from $6 and keeps a Buy rating on the shares. The firm updated its model for a reduction of Helixe bottles sold in 2026, decreasing to 50,000 from 105,000, which reduced its revenue estimate to $27.23M from $43.05M. It also added in the 12.5M shares that were issued in late February, which had a dilutive effect on its EPS estimates, the analyst tells investors.Claim 70% Off TipRanks PremiumUnlock
Top Midday Gainers
Hycroft Mining (HYMC) shares gained after the company said Monday its latest drilling program confir
Top Midday Decliners
EUDA Health (EUDA) said Monday that it is integrating the QB utility token into its digital health a
EUDA Health Holdings Limited (NASDAQ:EUDA) stock most popular amongst retail investors who own 47%, while private companies hold 26%
Key Insights The considerable ownership by retail investors in EUDA Health Holdings indicates that they collectively...
EUDA Health Holdings Full Year 2024 Earnings: US$0.54 loss per share (vs US$0.37 loss in FY 2023)
EUDA Health Holdings ( NASDAQ:EUDA ) Full Year 2024 Results Key Financial Results Revenue: US$4.01m (up 8.2% from FY...